Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Owlet Inc OWLT

Alternate Symbol(s):  OWLTW

Owlet, Inc. operates as a digital parenting platform company. The Company's platform focuses on giving real-time data and insights to parents. Its products include Owlet Dream Sock, an app to assist children with better sleep; Owlet Cam, a video streaming app to hear and see the baby from anywhere, and Owlet Monitor Duo. The Company offers sock monitor offerings, which include Smart Sock and Dream Sock and Dream Sock Plus. Its Cam offerings include Cam 1 and Cam 2. Its Monitor Duo and Dream Duo offer Sock Monitor offerings paired with the Owlet Cam offerings, combining the intelligence of its Sock Monitor offerings with high-definition video, offering parents the most complete picture of their baby’s sleep. Its accessories product line includes the Owlet Sleeper, a wearable rayon blanket that encourages safe sleep, best for babies ages three-six months old, and an Owlet Sock Travel Case.


NYSE:OWLT - Post by User

Comment by Chart1on May 10, 2023 12:44pm
56 Views
Post# 35441026

RE:OWLT - Wednesday Rundown, Thursday Expectations

RE:OWLT - Wednesday Rundown, Thursday ExpectationsThe company has some promise. It's all in the hands of the FDA unfortunately. It does appear that it would pass and recieve a medical device approval. If and when that happens the stock will certainly trade much higher. It appears to be the bottom now so I'll build out a small position here.
<< Previous
Bullboard Posts